- Home
- Publications
- Publication Search
- Publication Details
Title
Health benefits of methylxanthines in neurodegenerative diseases
Authors
Keywords
-
Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 61, Issue 6, Pages 1600670
Publisher
Wiley
Online
2017-01-11
DOI
10.1002/mnfr.201600670
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice
- (2017) Chuanhai Cao et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
- (2017) Gary W. Arendash et al. JOURNAL OF ALZHEIMERS DISEASE
- Concluding Remarks
- (2017) Alexandre Mendonça et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine and Coffee as Therapeutics Against Alzheimer's Disease
- (2017) Gary W. Arendash et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine as a Protective Factor in Dementia and Alzheimer's Disease
- (2017) Marjo H. Eskelinen et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine Intake and Dementia: Systematic Review and Meta-Analysis
- (2017) Catarina Santos et al. JOURNAL OF ALZHEIMERS DISEASE
- Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy
- (2016) Nicole R. Dobson et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline
- (2016) Afonso Moreira et al. JOURNAL OF ALZHEIMERS DISEASE
- High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies
- (2016) A K Hedström et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks
- (2016) João Monteiro et al. MOLECULES
- The potential of methylxanthine-based therapies in pediatric respiratory tract diseases
- (2016) Ainhoa Oñatibia-Astibia et al. RESPIRATORY MEDICINE
- Early synaptic deficits in the APP/PS1 mouse model of Alzheimer’s disease involve neuronal adenosine A2A receptors
- (2016) Silvia Viana da Silva et al. Nature Communications
- Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study
- (2015) Ronald B. Postuma et al. ANNALS OF NEUROLOGY
- Caffeine and Progression of Parkinson Disease
- (2015) David K. Simon et al. CLINICAL NEUROPHARMACOLOGY
- Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease
- (2015) Jacobus Petzer et al. CURRENT MEDICINAL CHEMISTRY
- Caffeine protects against experimental acute pancreatitis by inhibition of inositol 1,4,5-trisphosphate receptor-mediated Ca 2+ release
- (2015) Wei Huang et al. GUT
- Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory
- (2015) Anna G Orr et al. NATURE NEUROSCIENCE
- Caffeine Intake from Coffee or Tea and Cognitive Disorders: A Meta-Analysis of Observational Studies
- (2015) Young-Seok Kim et al. NEUROEPIDEMIOLOGY
- α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease
- (2015) Keiko Nakamura et al. NEUROPATHOLOGY
- Catecholaminergic and cholinergic systems of mouse brain are modulated by LMN diet, rich in theobromine, polyphenols and polyunsaturated fatty acids
- (2015) Laura Fernández-Fernández et al. Food & Function
- Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies
- (2015) Elinor Fondell et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
- (2014) Jie Liu et al. Channels
- Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors
- (2014) Lena Aronsen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- NMDA receptor modulators: an updated patent review (2013 – 2014)
- (2014) Katie L Strong et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Time-dependent enhancement of hippocampus-dependent memory after treatment with memantine: Implications for enhanced hippocampal adult neurogenesis
- (2014) Rie Ishikawa et al. HIPPOCAMPUS
- Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review
- (2014) Francesco Panza et al. Journal of Nutrition Health & Aging
- Trends in Caffeine Use and Association between Clinical Outcomes and Timing of Therapy in Very Low Birth Weight Infants
- (2014) Nicole R. Dobson et al. JOURNAL OF PEDIATRICS
- Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review
- (2014) Marla Rivera-Oliver et al. LIFE SCIENCES
- The prevalence of Parkinson's disease: A systematic review and meta-analysis
- (2014) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Genetic modifiers of Huntington's disease
- (2014) James F. Gusella et al. MOVEMENT DISORDERS
- Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease
- (2014) Gustavo Basurto-Islas et al. NEUROBIOLOGY OF AGING
- Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: Therapeutic window and receptor subtype mechanism
- (2014) Tan Wang et al. NEUROPHARMACOLOGY
- Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice
- (2014) M.Y. Liu et al. NEUROSCIENCE
- Improvement of mitochondrial NAD+/FAD+-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: Implications in Huntington's disease
- (2014) Jitendriya Mishra et al. Pharmacological Reports
- Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity
- (2014) Katherine Schoen et al. PEDIATRIC DRUGS
- GluN2B and GluN2D NMDARs dominate synaptic responses in the adult spinal cord
- (2014) Michael E. Hildebrand et al. Scientific Reports
- Effect of cocoa and theobromine consumption on serum HDL-cholesterol concentrations: a randomized controlled trial
- (2013) Nicole Neufingerl et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Caffeine and adenosine A2Areceptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease
- (2013) Nélio Gonçalves et al. ANNALS OF NEUROLOGY
- Istradefylline: First Global Approval
- (2013) Rosselle Dungo et al. DRUGS
- Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease
- (2013) Hui Qi et al. Geriatrics & Gerontology International
- Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis
- (2013) Rosa Luisa Potenza et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Dendritic spikes enhance stimulus selectivity in cortical neurons in vivo
- (2013) Spencer L. Smith et al. NATURE
- Association between caffeine intake and age at onset in Huntington's disease
- (2013) Clémence Simonin et al. NEUROBIOLOGY OF DISEASE
- Risk factors for dementia with Lewy bodies: A case-control study
- (2013) B. P. Boot et al. NEUROLOGY
- Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease
- (2013) Krystyna Gołembiowska et al. NEUROTOXICITY RESEARCH
- Health Benefits of Methylxanthines in Cacao and Chocolate
- (2013) Rafael Franco et al. Nutrients
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
- (2012) R. Liu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine
- (2012) Akira Nagakura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease
- (2012) Patricia K. Sonsalla et al. EXPERIMENTAL NEUROLOGY
- Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model
- (2012) Yi-Fang Chu et al. FOOD CHEMISTRY
- Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes
- (2012) Marco Matos et al. GLIA
- Caffeine and alcohol intakes have no association with risk of multiple sclerosis
- (2012) J Massa et al. Multiple Sclerosis Journal
- Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells
- (2012) Natasa Dragicevic et al. NEUROPHARMACOLOGY
- Spectral Analysis of Naturally Occurring Methylxanthines (Theophylline, Theobromine and Caffeine) Binding with DNA
- (2012) Irudayam Maria Johnson et al. PLoS One
- Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role
- (2011) Ettore Beghi et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease
- (2011) Anil Kachroo et al. ANNALS OF NEUROLOGY
- Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice
- (2011) Ross Zeitlin et al. BRAIN RESEARCH
- Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
- (2011) R. Gold et al. CLINICAL IMMUNOLOGY
- Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis
- (2011) M. B. D’hooghe et al. EUROPEAN JOURNAL OF NEUROLOGY
- The economic cost of brain disorders in Europe
- (2011) J. Olesen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Memantine attenuates the impairment of spatial learning and memory of pentylenetetrazol-kindled rats
- (2011) Li-Jing Jia et al. NEUROLOGICAL SCIENCES
- Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons
- (2011) S. Vila-Luna et al. NEUROSCIENCE
- Public financial support receipt and non-medical resource utilization in Alzheimer’s disease results from the PLASA study
- (2011) Thomas Rapp et al. SOCIAL SCIENCE & MEDICINE
- Longitudinal change in regional brain volumes in prodromal Huntington disease
- (2010) E. H. Aylward et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease
- (2010) K. Xu et al. NEUROSCIENCE
- Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats
- (2010) Jorge Camarasa et al. PHARMACOLOGICAL RESEARCH
- Comparison of Risk Factor Profiles in Incidental Lewy Body Disease and Parkinson Disease
- (2009) Roberta Frigerio et al. ARCHIVES OF NEUROLOGY
- Diet and Amyotrophic Lateral Sclerosis
- (2009) Natalia Morozova et al. EPIDEMIOLOGY
- Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by -Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
- (2009) P. M. Canas et al. JOURNAL OF NEUROSCIENCE
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Interactions Between Chronic Stress and Chronic Consumption of Caffeine on the Enzymatic Antioxidant System
- (2009) Cristie Grazziotin Noschang et al. NEUROCHEMICAL RESEARCH
- Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells
- (2009) Hélio Vitoriano Nobre et al. NEUROCHEMISTRY INTERNATIONAL
- Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels
- (2008) S. Guerreiro et al. MOLECULAR PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now